DB

Daniela Begolo

Managing Director at EQT Life Sciences

Amsterdam, North Holland

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $11,000,000.00

  • Max Investment:

    $65,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Molecular Biology
Biotechnology
Cell Culture
PCR
Western Blotting
Science
Cell Biology
Life Sciences
Molecular Cloning
Fluorescence Microscopy
Flow Cytometry
Bioinformatics
Research
Private Equity
Venture Capital
Start-ups
Healthcare Industry
Equity Research
Microsoft Office
Adobe Illustrator

Education

Work Experience

EQT Life Sciences

2023

  • Managing Director

    2023

INKEF Capital

2019 - 2022

  • Principal

    2022 - 2022

  • Senior Associate

    2020 - 2021

  • Associate

    2019 - 2020

M Ventures

2018 - 2019

  • Analyst

    2018 - 2019

    Part of the Healthcare team of M Ventures, corporate VC of Merck KGaA. Comprehensive due diligence to support strategic private equity investments in early stage biotech companies, in particular in oncology and immunology. Support to the team, in portfolio company strategy analysis.

ZMBH, University of Heidelberg

2013 - 2017

  • Postoctoral Researcher

    2017 - 2017

    Mode of action analysis of a small molecules compound series in the parasite T. brucei Independent development of research project; biochemistry, molecular biology and cell biology techniques; student supervision and mentorship

  • Early Stage Researcher, Marie Skłodowska-Curie Actions fellow

    2013 - 2017

    Development of molecular tools for drug target identification in T. brucei Autonomous development of research project; molecular biology, cell biology, genomics, metabolomics; frequent work-related traveling; student supervision